Welcome to LookChem.com Sign In|Join Free

CAS

  • or

552-41-0

Post Buying Request

552-41-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

552-41-0 Usage

Description

Paeonol is the main active ingredient of the cortex of thePaeonol raw materials with high purity can be derived from plant extracts by chemical synthesis. The commonly used extraction methods of paeonol include boiling method, alcohol extraction, steam distillation, and CO2 supercritical fluid extraction . But due to the limitation of plant resources and the lower content of paeonol in the natural plants, there are many separation and purification difficulties existed in the extraction methods. The chemical synthesis process is relatively easy, and the final product usually can be obtained through two- to three-step reaction and separation process . Ranunculaceae plants including Paeonia suffruticosa Andr. (Moutan cortex, Mudanpi) and Rhododendron plant Cynanchum paniculatum (Bge.) Kitag. (Cynanchi paniculati radix et rhizome, Xuchangqing). Moutan cortex and Xuchangqing are commonly used as traditional Chinese medicine. Moutan cortex has the effects on clearing heat, cooling blood, activating blood, resolving stasis, and retreating heat; Xuchangqing also has many effects, such as dispelling wind, relieving pain and itching, and so on.

Chemical Properties

white to beige crystalline powder

Physical properties

Appearance: white or light yellow, shining, needlelike crystals. Solubility: freely soluble in ethanol and methanol; soluble in diethyl ether, acetone, benzene, chloroform, and carbon disulfide; slightly soluble in water; and soluble in hot water, practically insoluble in cold water, and volatilizing in water vapor. Melting point: 48–51?°C.

History

As the main active ingredient of Moutan cortex and Xuchangqing, paeonol has been used in clinical practice since ancient times. Paeonol was first isolated from Moutan cortex by Japanese scholar Changjing Changyi in 1884 . This clinical observation was proceeded at more than 10 medical units in Shanghai and other places and lasted more than 1 year since 1971. Paeonol injection was the earliest recorded in the Chinese pharmacopoeia 1977 edition; it is the main formulation until now. But because of the poor water solubility of paeonol, it is necessary to improve its solubility to be used as injection. Ten times amount of Tween compared to paeonol was used in the injection to increase the dissolution. In the 1970s, paeonol was made into oil solution for intramuscular injection. But these are with security risks and the use of inconvenience and other shortcomings. Pharmacist obtained paeonol sodium sulfonate by sulfonated paeonol, so the problem of water solubility had been resolved, and the injection of paeonol sodium sulfonate also came into being . In 2003, the quality standard of paeonol sodium sulfonate was also promoted from the local standard to the national standard. The dosage form of paeonol for skin is mainly ointment.

Uses

Different sources of media describe the Uses of 552-41-0 differently. You can refer to the following data:
1. antibacterial, antimutagen, anti-alzheimer
2. An anti-inflammatory & anti-lipid peroxidation agent
3. Paeonol acting as a β-Secretase inhibitor an anti-apoptotic agent is used in the treatment of memory loss after ischemic stroke. Anti-inflammatory and analgesic.

Indications

This drug has been recorded in Pharmacopoeia of the People’s Republic of China (1977). At present, the dosage forms of paeonol for clinical use include tablet, ointment, injection, and plaster. Paeonol is clinically used for the treatment of fever, headache, neuralgia, muscle pain, abdominal pain, rheumatoid arthritis and rheumatoid arthritis; its ointment can also be used for a variety of eczema, dermatitis, skin itching, mosquito bite redness, and other skin diseases, also has a certain effect for allergic rhinitis, and is used for prevention of cold.

Preparation

Preparation by reaction of methyl iodide, or dimethyl sulfate on resacetophenone in sodium hydroxide or potassium hydroxide solution (quantitative yield) (70–75%).

General Description

This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. Produced by PhytoLab GmbH & Co. KG

Pharmacology

Paeonol has a wide range of pharmacological activities, and its antibacterial, antiinflammatory, antipyretic, analgesic, and antispasmodic pharmacological effects have been well known. With the recent further study of pharmacological effects of paeonol, the improvement of cardiovascular and cerebrovascular function, liver and kidney care, and antitumor, immune regulation, antioxidant, and other new pharmacological activities have also been reported successively. Studies have shown that the protective effects of paeonol on cardiovascular and cerebrovascular systems are displayed in three aspects: it has antiarrhythmic activity because of the blocking effect on calcium channel current; it can affect the endothelial cell inflammatory response, thus protecting the blood vessels and improving blood circulation; and it can stabilize the cell membrane and inhibit myocardial ischemia and membrane damage. Paeonol inhibits the proliferation of a variety of tumor cells, such as human leukemia cell line K562, human breast cancer gene T6-17, hepatocellular carcinoma cell line BEL-7404, hepatoma cell line HepA, human leukemia tumor cell line K562/ADM, cervical cancer cell line HeLa, human large intestine cancer cell line HT-29, and so on. It can also sensitize the multidrug resistance of tumor cells to the chemotherapy drugs. Low concentration of paeonol can increase the proportion of T lymphocytes in the blood circulation and also make T lymphocytes play a stronger lymphokine separation function but also can promote the non-specific phagocytic removal of bacteria function of neutrophil. The role of systemic cellular immunity and humoral immune function has also been experimentally confirmed. In addition, paeonol has a strong effect on scavenging free radical; its antioxidant effect also enables paeonol’s applications in the pharmaceutical field and food preservation industry.

Clinical Use

In clinical practice, paeonol is mainly used as a major active ingredient of multiflavor traditional Chinese medicine. For example, paeonol is the main active ingredient and quality control index of more than ten kinds of commonly used Chinese medicine preparations, such as Feng Shi Ding tablets, Liu Wei Di Huang pills, Zheng Gu Shui water, Gui Shao Di Huang Tang pills, Mai Wei Di Huang pills, Qi Ju Di Huang tablets, Ming Mu Di Huang pills, Zhi Bai Di Huang pills, Gu Ci pills, Gu Ci Xiao Tong tablets, Fu Fang Yi Gan pills, Yang Yin Qing Fei Tang pills, JiSheng Shen Qi Wan pills, and Danggui Yangxue pills. In addition, paeonol can also be administered as a monomeric drug. The listed preparations are mainly paeonol injection, paeonol tablets, and paeonol ointment, clinically for the treatment of rheumatism, stomachache, and other pains, eczema, allergic dermatitis, etc. Paeonol and its preparations have the characteristics of less side effect, no addictive, nonrebound, and high security.

Safety Profile

Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. When heated to decomposition it emits acrid smoke and irritating fumes.

Check Digit Verification of cas no

The CAS Registry Mumber 552-41-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,5 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 552-41:
(5*5)+(4*5)+(3*2)+(2*4)+(1*1)=60
60 % 10 = 0
So 552-41-0 is a valid CAS Registry Number.

552-41-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B22173)  2'-Hydroxy-4'-methoxyacetophenone, 99%   

  • 552-41-0

  • 5g

  • 251.0CNY

  • Detail
  • Alfa Aesar

  • (B22173)  2'-Hydroxy-4'-methoxyacetophenone, 99%   

  • 552-41-0

  • 25g

  • 1155.0CNY

  • Detail
  • Alfa Aesar

  • (B22173)  2'-Hydroxy-4'-methoxyacetophenone, 99%   

  • 552-41-0

  • 100g

  • 3898.0CNY

  • Detail

552-41-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Paeonol

1.2 Other means of identification

Product number -
Other names 2'-Hydroxy-4'-methoxyacetophenone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:552-41-0 SDS

552-41-0Synthetic route

2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

methyl iodide
74-88-4

methyl iodide

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With potassium carbonate In acetone at 80℃; for 6h;95%
With potassium carbonate In acetone Inert atmosphere; regioselective reaction;94%
With potassium carbonate In acetone for 22h; Heating;92%
2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
In methanol; diethyl ether Methylation;95%
In methanol; diethyl ether90%
2',4'-dimethoxyacetophenone
829-20-9

2',4'-dimethoxyacetophenone

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With aluminum (III) chloride In dichloromethane at -5 - 25℃;93%
With aluminium(III) iodide; N,N-dimethyl-formamide dimethyl acetal In acetonitrile at 80℃; for 18h;80%
With aluminium(III) iodide; N,N-dimethyl-formamide dimethyl acetal In acetonitrile at 80℃; for 18h;80%
With aluminium trichloride; benzene at 100 - 110℃;
With aluminium trichloride; benzene
2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

dimethyl sulfate
77-78-1

dimethyl sulfate

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With potassium carbonate In acetone for 0.333333h; Reflux;93%
With potassium carbonate In acetone at 20℃; for 5h;91%
Stage #1: 2',4'-dihydroxy-4-acetophenone With potassium carbonate In acetone for 0.166667h;
Stage #2: dimethyl sulfate In acetone at 20℃; for 12h;
88%
C9H12O3

C9H12O3

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With C6H4MoNO7(1-)*C19H42N(1+); oxygen In water at 100℃; for 20h; Green chemistry; chemoselective reaction;93%
1-(2-((tert-butyldimethylsilyl)oxy)-4-methoxyphenyl)ethan-1-one
462610-98-6

1-(2-((tert-butyldimethylsilyl)oxy)-4-methoxyphenyl)ethan-1-one

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With N,N,N',N'-tetramethylguanidine In acetonitrile at 20℃; for 0.333333h;90%
1-(2-bromo-4-methoxyphenyl)ethanone
89691-67-8

1-(2-bromo-4-methoxyphenyl)ethanone

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
Stage #1: 1-(2-bromo-4-methoxyphenyl)ethanone With copper(l) iodide; tetra(n-butyl)ammonium hydroxide In water at 60℃; for 24h; Inert atmosphere; Sealed tube;
Stage #2: With hydrogenchloride In water; ethyl acetate at 20℃; for 2h; Inert atmosphere; chemoselective reaction;
89%
dimethyl sulfoxide
67-68-5

dimethyl sulfoxide

dithiocarbonic acid ethyl ester [2-(2-hydroxy-4-methoxy-phenyl)-2-oxo-ethyl] ester
616892-31-0

dithiocarbonic acid ethyl ester [2-(2-hydroxy-4-methoxy-phenyl)-2-oxo-ethyl] ester

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
Stage #1: dimethyl sulfoxide With ferrous(II) sulfate heptahydrate; dihydrogen peroxide at 5 - 10℃; for 0.5h;
Stage #2: dithiocarbonic acid ethyl ester [2-(2-hydroxy-4-methoxy-phenyl)-2-oxo-ethyl] ester at 5 - 20℃; for 2.5h;
88%
methanol
67-56-1

methanol

2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran Cooling with ice;86.72%
acetic acid 3-methoxyphenyl ester
5451-83-2

acetic acid 3-methoxyphenyl ester

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With zirconium(IV) chloride In dichloromethane for 48h; Ambient temperature;85%
With aluminum (III) chloride at 150℃; for 3.5h;75%
With hafnium(IV) trifluoromethanesulfonate In nitromethane; toluene at 100℃; for 6h;53%
O-methylresorcine
150-19-6

O-methylresorcine

acetyl chloride
75-36-5

acetyl chloride

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With hafnium(IV) trifluoromethanesulfonate In nitromethane; toluene at 100℃; for 6h;84%
Stage #1: O-methylresorcine With titanium tetrachloride at 20℃;
Stage #2: acetyl chloride at 20 - 120℃; for 1.25h;
82%
boron trichloride In dichloromethane for 3h; Heating;78%
O-methylresorcine
150-19-6

O-methylresorcine

acetic anhydride
108-24-7

acetic anhydride

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In toluene for 2h; Reflux; Inert atmosphere;81%
O-methylresorcine
150-19-6

O-methylresorcine

acetic acid
64-19-7

acetic acid

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With zinc(II) chloride at 140 - 145℃; for 2h; Friedel Crafts acylation;80%
With hafnium tetrakis(trifluoromethanesulfonate) In nitromethane; toluene at 100℃; for 6h;65%
With zinc(II) chloride
With zinc(II) chloride Reflux;
O-methylresorcine
150-19-6

O-methylresorcine

acetyl chloride
75-36-5

acetyl chloride

A

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

B

1-(4-hydroxy-2-methoxy-phenyl)ethanone
493-33-4

1-(4-hydroxy-2-methoxy-phenyl)ethanone

Conditions
ConditionsYield
With scandium tris(trifluoromethanesulfonate) In nitromethane; toluene at 100℃; for 6h;A 80%
B 6%
2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

A

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

B

2',4'-dimethoxyacetophenone
829-20-9

2',4'-dimethoxyacetophenone

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate at 93℃; for 9h;A 6%
B 72%
acetic acid 3-methoxyphenyl ester
5451-83-2

acetic acid 3-methoxyphenyl ester

A

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

B

1-(4-hydroxy-2-methoxy-phenyl)ethanone
493-33-4

1-(4-hydroxy-2-methoxy-phenyl)ethanone

Conditions
ConditionsYield
With scandium tris(trifluoromethanesulfonate) In toluene at 100℃; for 6h; other reagent;A 65%
B 7%
With acetic acid; yttrium(III) trifluoromethanesulfonate In nitromethane at 100℃; for 2.5h; Fries rearrangement;A 60%
B 7%
With aluminium trichloride In nitrobenzene
With aluminium trichloride; nitrobenzene bei 24-stdg. Behandeln;
With aluminium trichloride; nitrobenzene bei 0.5-stdg. Erwaermen;
1-(4-methoxy-2-((3-methylbut-2-en-1-yl)oxy)phenyl)ethan-1-one
128961-25-1

1-(4-methoxy-2-((3-methylbut-2-en-1-yl)oxy)phenyl)ethan-1-one

A

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

B

1-(2-hydroxy-4-methoxy-3-(3-methyl-butyl-2-ene-1-yl)phenyl)ethanone
52601-06-6

1-(2-hydroxy-4-methoxy-3-(3-methyl-butyl-2-ene-1-yl)phenyl)ethanone

C

2′-hydroxyl-4′-methoxyl-5′-isopentenylacetophenone
28448-83-1

2′-hydroxyl-4′-methoxyl-5′-isopentenylacetophenone

D

2'-hydroxy-4'-methoxy-3',5'-diprenylacetophenone
50773-40-5

2'-hydroxy-4'-methoxy-3',5'-diprenylacetophenone

Conditions
ConditionsYield
With Montmorillonite K10 In dichloromethane at 0℃; for 0.5h;A 4%
B 53%
C 25%
D 7%
With montmorillonite K10 In dichloromethane at 0℃; for 0.5h;A 4%
B 53%
C 17%
D 7%
2',4'-dimethoxyacetophenone
829-20-9

2',4'-dimethoxyacetophenone

A

2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

B

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

C

1-(4-hydroxy-2-methoxy-phenyl)ethanone
493-33-4

1-(4-hydroxy-2-methoxy-phenyl)ethanone

Conditions
ConditionsYield
With 1-methyl-pyrrolidin-2-one; potassium carbonate; thiophenol for 0.5h; Heating;A 22%
B 16.3%
C 38%
1-(4-methoxy-2-((3-methylbut-2-en-1-yl)oxy)phenyl)ethan-1-one
128961-25-1

1-(4-methoxy-2-((3-methylbut-2-en-1-yl)oxy)phenyl)ethan-1-one

A

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

B

1-(2-hydroxy-4-methoxy-3-(3-methyl-butyl-2-ene-1-yl)phenyl)ethanone
52601-06-6

1-(2-hydroxy-4-methoxy-3-(3-methyl-butyl-2-ene-1-yl)phenyl)ethanone

C

2′-hydroxyl-4′-methoxyl-5′-isopentenylacetophenone
28448-83-1

2′-hydroxyl-4′-methoxyl-5′-isopentenylacetophenone

D

8-acetyl-2,2-dimethyl-5-methoxychroman
32541-39-2

8-acetyl-2,2-dimethyl-5-methoxychroman

Conditions
ConditionsYield
With florisil In toluene at 110℃; for 2h;A 10%
B 27%
C 32%
D 8%
7-methoxy-4H-chromen-4-one
5751-52-0

7-methoxy-4H-chromen-4-one

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With sodium hydrogen telluride In ethanol for 15h; Heating; buffered;30%
With sodium hydrogen telluride In ethanol for 15h; Heating;30%
7-methoxy-2-methyl-chromen-4-one
26213-82-1

7-methoxy-2-methyl-chromen-4-one

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With sodium hydrogen telluride In ethanol for 15h; Heating; buffered;30%
With sodium hydrogen telluride In ethanol for 15h; Heating;30%
1-(4-methoxyphenyl)ethanone
100-06-1

1-(4-methoxyphenyl)ethanone

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With palladium diacetate; Selectfluor; trifluoroacetic acid; trifluoroacetic anhydride at 50℃; for 12h; Sealed tube; regioselective reaction;30%
With dipotassium peroxodisulfate; palladium diacetate; trifluoroacetic acid; trifluoroacetic anhydride at 50 - 90℃; regioselective reaction;30%
Multi-step reaction with 2 steps
1: palladium diacetate; dipotassium peroxodisulfate / 4 h / 50 °C
2: silica gel / hexane; dichloromethane
View Scheme
2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With water; silver nitrate und Erwaermen des erhaltenen Silber-Salzes mit Methyljodid in Aceton;
With potassium carbonate; methyl iodide In acetone at 20℃; Further stages;
2-hydroxy-4-methoxyacetophenone-OAc
59263-73-9

2-hydroxy-4-methoxyacetophenone-OAc

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With potassium hydroxide
acetic acid
64-19-7

acetic acid

1,3-Dimethoxybenzene
151-10-0

1,3-Dimethoxybenzene

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With boron trifluoride
O-methylresorcine
150-19-6

O-methylresorcine

acetonitrile
75-05-8

acetonitrile

A

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

B

1-(4-hydroxy-2-methoxy-phenyl)ethanone
493-33-4

1-(4-hydroxy-2-methoxy-phenyl)ethanone

Conditions
ConditionsYield
With hydrogenchloride; diethyl ether; zinc(II) chloride und Erwaermen des Reaktionsprodukts in Benzol mit wss.HCl;
2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

methyl iodide
74-88-4

methyl iodide

A

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

B

1-(2-hydroxy-4-methoxy-3-methylphenyl)ethanone
69469-91-6

1-(2-hydroxy-4-methoxy-3-methylphenyl)ethanone

C

1-(2,4-dihydroxy-3-methylphenyl)ethanone
10139-84-1

1-(2,4-dihydroxy-3-methylphenyl)ethanone

4-amino-7-methoxy-2H-chromen-2-one
79492-23-2

4-amino-7-methoxy-2H-chromen-2-one

alkali

alkali

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

4-acetylamino-7-methoxy-coumarin

4-acetylamino-7-methoxy-coumarin

alkali

alkali

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

benzoyl chloride
98-88-4

benzoyl chloride

benzoic acid 2-acetyl-5-methoxyphenyl ester
124260-01-1

benzoic acid 2-acetyl-5-methoxyphenyl ester

Conditions
ConditionsYield
With pyridine for 6h; Ambient temperature;100%
With pyridine at 70℃;96%
With dmap In pyridine for 0.166667h;84%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

2,4-Dimethoxybenzaldehyde
613-45-6

2,4-Dimethoxybenzaldehyde

(E)-1-(2-hydroxy-4-methoxyphenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one
36685-67-3, 84426-23-3

(E)-1-(2-hydroxy-4-methoxyphenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one

Conditions
ConditionsYield
With potassium hydroxide In ethanol at 20℃; for 16h; Claisen-Schmidt Condensation;100%
With sodium hydroxide In ethanol at 20℃; for 16h;94%
With potassium hydroxide In ethanol at 20℃; Claisen Schmidt condensation;90%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

2,2-dihydroxyacetic acid
563-96-2

2,2-dihydroxyacetic acid

2-Hydroxy-4-(2-hydroxy-4-methoxy-phenyl)-4-oxo-butyric acid
117379-73-4

2-Hydroxy-4-(2-hydroxy-4-methoxy-phenyl)-4-oxo-butyric acid

Conditions
ConditionsYield
at 95℃; under 50 Torr; for 3h;100%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

2,6-dimethoxybenzaldehyde
3392-97-0

2,6-dimethoxybenzaldehyde

(2E)-3-(2,6-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one

(2E)-3-(2,6-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 20℃; Aldol Condensation;100%
With potassium hydroxide In methanol at 70℃; Claisen-Schmidt condensation;80%
Stage #1: 1-(2-hydroxy-4-methoxyphenyl)ethanone With sodium hydroxide In ethanol; water at 20℃; for 0.0833333h; Claisen-Schmidt Condensation;
Stage #2: 2,6-dimethoxybenzaldehyde at 20℃; Claisen-Schmidt Condensation;
74%
With barium dihydroxide In ethanol for 2h; Heating;20%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

3,3-dimethyl-allyl chloride
503-60-6

3,3-dimethyl-allyl chloride

1-(4-methoxy-2-((3-methylbut-2-en-1-yl)oxy)phenyl)ethan-1-one
128961-25-1

1-(4-methoxy-2-((3-methylbut-2-en-1-yl)oxy)phenyl)ethan-1-one

Conditions
ConditionsYield
With potassium carbonate In acetone Heating;100%
With potassium carbonate In acetone for 24h; Reflux;91%
With potassium carbonate In acetone for 24h; Reflux;91%
With potassium carbonate In acetone Inert atmosphere;
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

2-(1-iminoethyl)-5-methoxyphenol
1021267-09-3

2-(1-iminoethyl)-5-methoxyphenol

Conditions
ConditionsYield
With ammonia In methanol at 20℃; Cooling with ice;100%
4-methylthiophene-2-carbaldehyde
6030-36-0

4-methylthiophene-2-carbaldehyde

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

(E)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-methylthiophen-2-yl)prop-2-en-1-one

(E)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-methylthiophen-2-yl)prop-2-en-1-one

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 20℃; Claisen-Schmidt Condensation;100%
cycl-isopropylidene malonate
2033-24-1

cycl-isopropylidene malonate

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

4-methyl-7-methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid
91570-50-2

4-methyl-7-methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid

Conditions
ConditionsYield
With vinegar In water at 20℃; for 0.0833333h; Reagent/catalyst; Knoevenagel Condensation; Sonication; Green chemistry;99%
Stage #1: 1-(2-hydroxy-4-methoxyphenyl)ethanone With ammonia In methanol at 20℃;
Stage #2: cycl-isopropylidene malonate In ethanol for 5h; Heating;
60%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

(E)-3-(4-bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one

(E)-3-(4-bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one

Conditions
ConditionsYield
Stage #1: 1-(2-hydroxy-4-methoxyphenyl)ethanone; 4-bromo-benzaldehyde With potassium hydroxide In methanol at 60℃;
Stage #2: With hydrogenchloride In methanol; water pH=2; Cooling with ice;
99%
With barium dihydroxide In ethanol for 2h; Heating;84%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

C9H12N2O2

C9H12N2O2

Conditions
ConditionsYield
With hydrazine hydrate In ethanol at 20℃;99%
ethyl bromide
74-96-4

ethyl bromide

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

1-(2-ethoxy-4-methoxyphenyl)ethanone
67082-94-4

1-(2-ethoxy-4-methoxyphenyl)ethanone

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl-formamide at 45℃;98.2%
With potassium carbonate In N,N-dimethyl-formamide; acetone at 60℃; for 3h;75.6%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

oxalic acid diethyl ester
95-92-1

oxalic acid diethyl ester

7-methoxy-4-oxo-4H-chromene-2-carboxylic acid ethyl ester
38322-74-6

7-methoxy-4-oxo-4H-chromene-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With sodium ethanolate In ethanol for 1h; Heating;98%
With sodium ethanolate In ethanol for 1h; Heating / reflux;98%
With sodium ethanolate In ethanol for 1h; Kostanecki-Robinson Reaction;98%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

Diethyl carbonate
105-58-8

Diethyl carbonate

4-hydroxy-7-methoxycoumarine
17575-15-4

4-hydroxy-7-methoxycoumarine

Conditions
ConditionsYield
With sodium hydride In mineral oil at 0 - 85℃; for 14h;98%
With sodium hydride In mineral oil at 0 - 100℃;95%
With sodium hydride In toluene; mineral oil at 100℃; for 4.5h;92%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

2-acetyl-5-methoxyphenyl methanesulfonate
225939-44-6

2-acetyl-5-methoxyphenyl methanesulfonate

Conditions
ConditionsYield
With triethylamine In dichloromethane98%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

benzyl bromide
100-39-0

benzyl bromide

2-benzyloxy-4-methoxyacetophenone
52249-86-2

2-benzyloxy-4-methoxyacetophenone

Conditions
ConditionsYield
With 18-crown-6 ether; potassium carbonate In acetone for 5h; Heating;97%
With sodium hydroxide; benzyl tri-n-butylammonium bromide In dichloromethane; water at 20℃; for 12h; Substitution;96%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18h;87%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

4-methyl-benzaldehyde
104-87-0

4-methyl-benzaldehyde

(E)-1-(2-hydroxy-4-methoxyphenyl)-3-p-tolylprop-2-en-1-one
137109-37-6

(E)-1-(2-hydroxy-4-methoxyphenyl)-3-p-tolylprop-2-en-1-one

Conditions
ConditionsYield
With potassium hydroxide In ethanol; water at 20℃; Claisen-Schmidt Condensation; Sonication;97%
With potassium hydroxide In methanol at 20℃;
methyl magnesium iodide
917-64-6

methyl magnesium iodide

1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

2-(2-hydroxypropan-2-yl)-5-methoxyphenol

2-(2-hydroxypropan-2-yl)-5-methoxyphenol

Conditions
ConditionsYield
Stage #1: methyl magnesium iodide; 1-(2-hydroxy-4-methoxyphenyl)ethanone In diethyl ether at 0℃;
Stage #2: With ammonium chloride In water
97%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

carbon monoxide
201230-82-2

carbon monoxide

4-hydroxy-7-methoxycoumarine
17575-15-4

4-hydroxy-7-methoxycoumarine

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 80℃; under 7355.08 Torr; for 4h;96%
With selenium; 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran at 100℃; under 22800 Torr; for 30h;36%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

ethylhydrazine carboxylate
4114-31-2

ethylhydrazine carboxylate

2-hydroxy-4-methoxyacetophenone ethoxycarbonylhydrazone
132338-33-1

2-hydroxy-4-methoxyacetophenone ethoxycarbonylhydrazone

Conditions
ConditionsYield
With hydrogenchloride In ethanol at 80℃; for 2h;96%
In propan-1-ol for 24h; Heating;85%
In benzene for 48h; Ambient temperature;79%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

1-phenylmethyl-4-piperidone
3612-20-2

1-phenylmethyl-4-piperidone

1'-benzyl-7-methoxyspiro[chromene-2,4'-piperidin]-4(3H)-one
868361-89-1

1'-benzyl-7-methoxyspiro[chromene-2,4'-piperidin]-4(3H)-one

Conditions
ConditionsYield
With L-proline In N,N-dimethyl-formamide at 80℃; for 10h;96%
pyrrolidine In methanol Heating;86%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

acetone
67-64-1

acetone

7-methoxy-2,2-dimethyl-4-chromanone
20321-73-7

7-methoxy-2,2-dimethyl-4-chromanone

Conditions
ConditionsYield
With pyrrolidine In ethanol for 14h; Heating;96%
With pyrrolidine In ethanol for 6h; Reflux;82%
With pyrrolidine In ethanol for 12h; Inert atmosphere; Reflux;79.3%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

bis(2-methylbenzyl) ether
16814-26-9

bis(2-methylbenzyl) ether

2-acetyl-5-methoxyphenyl 2-methylbenzoate
1607006-50-7

2-acetyl-5-methoxyphenyl 2-methylbenzoate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; copper diacetate In decane; dimethyl sulfoxide at 80℃; for 20h; Reagent/catalyst; Sealed tube; chemoselective reaction;96%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

C18H18O5

C18H18O5

2-acetyl-5-methoxyphenyl 4-methoxybenzoate
134700-82-6

2-acetyl-5-methoxyphenyl 4-methoxybenzoate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; copper(l) iodide In decane; dimethyl sulfoxide at 80℃; for 20h; Sealed tube; chemoselective reaction;96%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

3,4-dichlorobenzaldehyde
6287-38-3

3,4-dichlorobenzaldehyde

C16H12Cl2O3

C16H12Cl2O3

Conditions
ConditionsYield
With potassium hydroxide In ethanol; water at 20℃; Claisen-Schmidt Condensation; Sonication;96%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

acetyl chloride
75-36-5

acetyl chloride

2-hydroxy-4-methoxyacetophenone-OAc
59263-73-9

2-hydroxy-4-methoxyacetophenone-OAc

Conditions
ConditionsYield
With pyridine at 20℃; for 2h; Inert atmosphere;96%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

cinnamyl chloride
2687-12-9

cinnamyl chloride

1-[4-methoxy-2-(3-phenylallyloxy)phenyl]ethanone

1-[4-methoxy-2-(3-phenylallyloxy)phenyl]ethanone

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 25℃; for 20h; Reflux; Inert atmosphere;96%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

3,4-dimethoxy-benzaldehyde
120-14-9

3,4-dimethoxy-benzaldehyde

2'-hydroxy-3,4,4'-trimethoxychalcone
57601-14-6

2'-hydroxy-3,4,4'-trimethoxychalcone

Conditions
ConditionsYield
With potassium hydroxide In ethanol; water at 20℃; Claisen-Schmidt Condensation; Sonication;95%
With potassium hydroxide In ethanol at 40℃; Claisen-Schmidt Condensation; Sonication;95%
With sodium hydroxide In ethanol at 20℃; Claisen-Schmidt condensation;89%
1-(2-hydroxy-4-methoxyphenyl)ethanone
552-41-0

1-(2-hydroxy-4-methoxyphenyl)ethanone

N,N-Dimethylthiocarbamoyl chloride
16420-13-6

N,N-Dimethylthiocarbamoyl chloride

O-2-acetyl-5-methoxyphenyl N,N-dimethylcarbamothioate
107514-46-5

O-2-acetyl-5-methoxyphenyl N,N-dimethylcarbamothioate

Conditions
ConditionsYield
With 1,4-diaza-bicyclo[2.2.2]octane In N,N-dimethyl-formamide at 50℃; for 5h; Inert atmosphere;95%
With sodium hydride In N,N-dimethyl-formamide for 18h; Ambient temperature; 1.) DMF, RT, 2.) 18 h;48%

552-41-0Relevant articles and documents

Synthesis, vibrational, NMR, quantum chemical and structure-activity relation studies of 2-hydroxy-4-methoxyacetophenone

Arjunan,Devi,Subbalakshmi,Rani,Mohan

, p. 164 - 177 (2014)

The stable geometry of 2-hydroxy-4-methoxyacetophenone is optimised by DFT/B3LYP method with 6-311++G* and cc-pVTZ basis sets. The structural parameters, thermodynamic properties and vibrational frequencies of the optimised geometry have been determined. The effects of substituents (hydroxyl, methoxy and acetyl groups) on the benzene ring vibrational frequencies are analysed. The vibrational frequencies of the fundamental modes of 2-hydroxy-4-methoxyacetophenone have been precisely assigned and analysed and the theoretical results are compared with the experimental vibrations. 1H and 13C NMR isotropic chemical shifts are calculated and assignments made are compared with the experimental values. The energies of important MO's, the total electron density and electrostatic potential of the compound are determined. Various reactivity and selectivity descriptors such as chemical hardness, chemical potential, softness, electrophilicity, nucleophilicity and the appropriate local quantities are calculated.

Synthesis of novel isoflavone/benzo-δ-sultam hybrids as potential anti-inflammatory drugs

Mengheres, Gabriel,Rice, Craig R.,Olajide, Olumayokun A.,Hemming, Karl

supporting information, (2021/01/12)

A small series of novel isoflavone/benzo-δ-sultam hybrids was synthesised and evaluated as potential anti-inflammatory and neuroprotective drugs in LPS-activated BV2 microglia. The benzo-δ-sultam core was constructed in a two-step reaction by coupling 2-halobenzenesulfonamide derivatives with terminal alkynes, followed by a 6-endo-dig cyclisation. The synthesised compounds, including precursors and hybrids, were tested for their ability to inhibit NO and TNF-α production in LPS-stimulated BV2 microglial cells, and the results are promising. The most potent hybrid reduces the NO production to 41%, and the TNF-α to 34% at 20 μM final concentration in the well.

Anti‐melanogenic properties of velutin and its analogs?

Choe, Jung-Won,Heo, Hee-Young,Jung, Se-Hui,Kim, Jaehyun,Lee, Kooyeon

, (2021/06/03)

Velutin, one of the flavones contained in natural plants, has various beneficial activities, such as skin whitening, as well as anti‐inflammatory, anti‐allergic, antioxidant, and antimicrobial activities. However, the relationship between the structure of velutin and its anti‐melanogenesis activity is not yet investigated. In this study, we obtained 12 velutin derivatives substituted at C5, C7, C3′, and C4′ of the flavone backbone with hydrogen, hydroxyl, and methoxy functionalities by chemical synthesis, to perform SAR analysis of velutin structural analogues. The SAR study revealed that the substitution of functional groups at C5, C7, C3′, and C4′ of the flavone backbone affects biological activities related to melanin synthesis. The coexistence of hydroxyl and methoxy at the C5 and C7 position is essential for inhibiting tyrosinase activity. However, 1,2‐diol compounds substituted at C3′ and C4′ of flavone backbone induce apoptosis of melanoma cells. Further, substitution at C3′ and C4′ with methoxy or hydrogen is essential for inhibiting melanogenesis. Thus, this study would be helpful for the development of natural‐derived functional materials to regulate melanin synthesis.

Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo

He, Zhendan,Huang, Jian,Pan, Dabo,Wang, Jinhui,Yao, Dahong,Zhang, Jin,Zhen, Yongqi

, (2019/12/26)

Ferulin C, a natural sesquiterpene coumarin, isolated from the roots of Ferula ferulaeoides (Steud.) Korov, displaying potent antiproliferatory activity against breast cancer cells. This study aimed to elucidate the underlying molecular mechanisms of Ferulin C-induced breast cancer cells death in vitro and in vivo. Ferulin C presented potent antiproliferatory activity against MCF-7 and MDA-MB-231 cells and remarkable tubulin polymerization inhibitory activity (IC50 = 9.2 μM). Meanwhile, we predicted Ferulin C bind to the Colchicine site of tubulin through CETSA assay, molecular docking and molecular dynamics (MD) simulations. In immunofluorescence assay, Ferulin C disturbed the microtubule integrity and structure. Furthermore, Ferulin C stimulated significant cell cycle arrest in the G1/S period via p21Cip1/Waf1 - CDK2 signaling, induced classic cell apoptosis, impaired metastasis via down-regulating Ras-Raf-ERK and AKT-mTOR signaling. Intriguingly, Ferulin C treatment induced autophagy by ULK1 signaling to synergize with the inhibition of proliferation and metastasis. Based upon the RNAseq analysis, PAK1, as a novel essential modulator, was involved in the signaling regulated by Ferulin C -induced α/β-tubulin depolymerization. Additionally, Ferulin C displayed an acceptable antiproliferatory activity in an MCF-7 xenograft model without inducing obvious weight loss in the Ferulin C treated mice. Summarily, our findings substantiated that Ferulin C was a potent, colchicine site binding microtubule-destabilizing agent with anti-proliferation and anti-metastasis activity via PAK1 and p21-mediated signaling in breast cancer cells.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 552-41-0